Table 4 Checklist for assessing appropriateness of digitally-supported patient-centered follow-up
Favorable Factors | Unfavorable Factors |
|---|---|
+ Consent to participate in flexible digitally-supported patient-centered follow-up | + No Consent to participate in flexible digitally-supported patient-centered follow-up |
+ Patients in remission | + Patients in an acute situation |
+ High health literacy and disease knowledge | + Low health literacy and missing disease knowledge |
+ Smartphone, technical skills | + No smartphone, low technical skills |
+ Disease with serological biomarker(s) relevant for disease monitoring (systemic lupus erythematosus, vasculitis, rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, autoinflammatory diseases) | + No clinically relevant serological bio-marker available (i.e. osteoarthritis) |
+ Analysis of few biomarkers sufficient (i.e. CRP, anti-dsDNA) | + Under anticoagulant therapy |
+ Long travel / queue time for venous blood collection | + Poor wound healing, eczema and other inflammatory skin disease |
+ Limited availability due to work/family responsibilities | + Reduced finger strength/function and pain |
+ Immobile patient (high effort/burden associated with medical consultation) | + Impaired vision |
+ High patient adherence | + Previous failure of blood self-collection |
+ Longer disease duration | + No interest in self-collection |